Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia

Brain Research

Volumn 810, Issue 1-2, 1998, Pages 181-199

  Minger, Stephen L ^a   Geddes, James W ^a   Holtz, Mary L ^b,c   Craddock, Susan D ^e   Whiteheart, Sidney W ^a   Siman, Robert G ^d   Pettigrew, L Creed ^a,b,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c LEXINGTON VA MEDICAL CENTER   (United States)

^d CEPHALON INC   (United States)

^e NONE

Author keywords

Calpain; Cerebral ischemia; Microtubule associated protein; Neuronal degeneration

Indexed keywords

CALPAIN; GLUTAMATE RECEPTOR ANTAGONIST; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CYTOSKELETON; MALE; MICROTUBULE; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; BLOTTING, WESTERN; CALPAIN; CEREBRAL INFARCTION; CYTOSKELETON; EXCITATORY AMINO ACID ANTAGONISTS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PIPECOLIC ACIDS; QUINOXALINES; RATS; RATS, INBRED SHR; RECEPTORS, GLUTAMATE; SPECTRIN; SYNAPTIC TRANSMISSION; TAU PROTEINS;

EID: 0032501191     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00921-4     Document Type: Article

References (66)

1. Bartus R.T. The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway. The Neuroscientist. 3:1997;314-327.
2. Bartus R.T., Dean R.L., Cavanaugh K., Eveleth D., Carriero D.L., Lynch G. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15:1995;969-979.
3. Baudry M., DuBrin R., Lynch G. Subcellular compartmentalization of calcium-dependent and calcium-independent neutral proteases in brain. Synapse. 1:1987;506-511.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;472-476.
5. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
6. Benveniste H., Jorgensen M.B., Sandberg M., Christensen T., Hagberg H., Diemer N.H. Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3. J. Cereb. Blood Flow Metab. 9:1989;629-639.
7. Binder L.I., Frankfurter A., Rebhun L.I. The distribution of tau in the mammalian central nervous system. J. Cell Biol. 101:1985;1371-1378.
8. Binder L.I., Frankfurter A., Rebhun L.I. Differential localization of MAP-2 and tau in mammalian neurons in situ. Annals of the New York Academy of Sciences. 466:1986;145-166.
9. Boast C.A., Gerhardt S.C., Pastor G., Lehmann J., Etienne P.E., Liebman J.M. The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res. 442:1988;345-348.
10. Brint S., Jacewicz M., Kiessling M., Tanabe J., Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral artery and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8:1988;474-485.
11. Buchan A., Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10:1990;311-316.
12. Butcher S.P., Bullock R., Graham D.I., McCullough J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21:1990;1727-1733.
13. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71:1991;813-847.
14. Davis D.R., Brion J.P., Couck A.M., Gallo J.M., Hanger D.P., Ladhani K., Lewis C., Lewis C.C.J., Rupniak T., Smith C., Anderton B.H. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem. J. 309:1995;941-949.
15. Dawson D.A., Hallenbeck J.M. Acute focal ischemia-induced alterations in MAP2 immunostaining: description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J. Cereb. Blood Flow Metab. 16:1996;170-174.
16. DeGraba T.J., Ostrow P.T., Grotta J.C. Threshold of calcium disturbances after focal cerebral ischemia in rats. Implications of the window of therapeutic opportunity. Stroke. 24:1993;1212-1217.
17. del Cerro S., Arai A., Kessler M., Bahr B.A., Vanderklish P., Rivera S., Lynch G. Stimulation of NMDA receptors activates calpain in cultured hippocampal slices. Neurosci. Lett. 167:1994;149-152.
18. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., Farber N., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123:1993;204-215.
19. Geddes J.W., Bondada M., Keller J.N. Effects of intrahippocampal colchicine administration on the levels and localization of microtubule-associated proteins, tau and MAP2. Brain Res. 633:1994;1-8.
20. Geddes J.W., Pettigrew L.C., Holtz M.L., Craddock S.D., Maines M.D. Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase-2, protein in rat brain. Neurosci. Lett. 210:1996;205-208.
21. Geddes J.W., Schwab C., Craddock S., Wilson J.L., Pettigrew L.C. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J. Cereb. Blood Flow Metab. 14:1994;554-564.
22. Gill R., Nordholm L., Lodge D. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brain Res. 580:1992;35-43.
23. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlain M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4913-4919.
24. Hamakubo T., Kannagi R., Murachi T., Matus A. Distribution of calpains I and II in rat brain. J. Neurosci. 6:1986;3103-3111.
25. Hillered L., Hallström A., Segersvärd S., Persson L., Ungerstedt U. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J. Cereb. Blood Flow Metab. 9:1989;607-616.
26. Inuzuka T., Tamura A., Sato S., Kirino T., Toyoshima I., Miyatake T. Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats. Brain Res. 526:1990;177-179.
27. Irving E.A., McCulloch J., Dewar D. Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Acta Neuropathol. 92:1996;186-196.
28. Johnson G.V.W., Jope R.S., Binder L.I. Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163:1989;1505-1511.
29. Johnson G.V.W., Litersky J.M., Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56:1991;1630-1638.
30. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischaemia. Brain Res. 239:1982;57-69.
31. Kitagawa K., Matsumoto M., Niinobe M., Mikoshiba K., Hata R., Udea H., Handa N., Fukunaga R., Isaka Y., Kimura K., Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage: immunohistochemical investigation of dendritic damage. Neuroscience. 31:1989;401-411.
32. Kristián T., Siesjö B.K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
33. Le Peillet E., Arvin B., Moncada C., Meldrum B.S. The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res. 571:1992;115-120.
34. Lee K.S., Frank S., Vanderklish P., Arai A., Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7233-7237.
35. Li H., Buchan A.M. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13:1993;933-939.
36. Li J., Grynspan F., Berman S., Nixon R., Bursztajn S. Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30:1996;177-191.
37. Litersky J.M., Johnson G.V.W. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267:1992;1563-1568.
38. Manev H., Favaron M., Siman R., Guidotti A., Costa E. Glutamate neurotoxicity is independent of calpain I inhibition in primary cultures of cerebellar granule cells. J. Neurochem. 57:1991;1288-1295.
39. Markgraf C.G., Velayo N.L., Johnson M.P., McCarty D.R., Mehdi S., Koehl J.R., Chmielewski P.A., Linnik M.D. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke. 29:1998;152-158.
40. Matesic D.F., Lin R.C.S. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J. Neurochem. 63:1994;1012-1020.
41. Melloni E., Pontremoli S. The calpains. Trends Neurosci. 12:1989;438-444.
42. Mercken M., Grynspan F., Nixon R.A. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Letters. 368:1995;10-14.
43. Miyazawa T., Bonnekoh P., Hossman K.A. Temperature effect on immunostaining of microtubule-associated protein 2 and synaptophysin after 30 minutes of forebrain ischemia. Acta Neuropathol. 85:1993;526-532.
44. Nellgård B., Wieloch T. Postischemic blockage of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12:1992;2-11.
45. Perlmutter L.S., Gall C., Baudry M., Lynch G. Distribution of calcium-activated protease calpain in the rat brain. J. Comp. Neurol. 296:1990;269-276.
46. Perlmutter L.S., Siman R., Gall C., Seubert P., Baudry M., Lynch G. The ultrastructural localization of calcium-activated protease 'calpain' in rat brain. Synapse. 2:1988;79-88.
47. Pettigrew L.C., Holtz M.L., Craddock S.D., Minger S.L., Hall N., Geddes J.W. Microtubular proteolysis in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;1189-1202.
48. Rami A., Krieglstein J. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res. 609:1993;67-70.
49. Roberts-Lewis J.M., Savage M.J., Marcy V.L., Pinsker L.R., Siman R. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14:1994;3934-3944.
50. Schwab C., Bondada V., Sparks D.L., Cahan L.D., Geddes J.W. Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus. Hippocampus. 4:1994;210-225.
51. Seubert P., Larson J., Oliver M., Jung M.W., Baudry M., Lynch G. Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus. Brain Res. 460:1988;189-194.
52. Seubert P., Lee K., Lynch G. Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res. 492:1989;366-370.
53. Sharp F.R., Jasper P., Hall J., Noble L., Sagar S.M. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30:1991;801-809.
54. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honore T. 2,3-dihyroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
55. Siman R., Noszek J.C. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron. 1:1988;279-287.
56. Siman R., Noszek J.C., Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J. Neurosci. 9:1989;1579-1590.
57. Simon R.P., Shiraishi K. N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann. Neurol. 27:1990;606-611.
58. Smith-Swintowski V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., Mattson M.P. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J. Cereb. Blood Flow Metab. 16:1996;585-598.
59. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem. J. 328:1997;721-732.
60. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:1990;290-293.
61. Tomioka C., Nishioka H., Kogure K. Absence of early destructive changes of cytoskeletal proteins after transient ischemia in the rat. Brain Res. 586:1992;352-357.
62. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 45:1995;788-793.
63. Yamamoto K., Morimoto K., Yanagihara T. Cerebral ischemia in the gerbil: transmission electron microscopic and immunoelectron microscopic investigation. Brain Res. 384:1986;1-10.
64. Yamashita T., Tada K., Sobue K., Niigawa H., Suzuki H., Hariguchi S., Nishimura T. Effect of transient ischemia on brain proteins in Mongolian gerbil. Neurochem. Res. 11:1986;1728-1729.
65. Yang L.S., Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur. J. Biochem. 233:1995;9-17.
66. Yao H., Ginsberg M.D., Eveleth D.D., LaManna J.C., Watson B.D., Alonso O.F., Loor J.Y., Foreman J.H., Busto R. Local cerebral glucose utilization and cytoskeletal proteolysis as indices of evolving focal ischemic injury in core and penumbra. J. Cereb. Blood Flow Metab. 15:1995;398-408.